L01D antineoplastic antibiotics Antibióticos citotóxicos y sustancias relacionadas 细胞毒素抗生素及相关物质 細胞毒素抗生素及相關物質 L3
Source: Wikidata · CC0 1.0 Fuente: Wikipedia · CC BY-SA 4.0 来源:维基百科 · CC BY-SA 4.0 來源:維基百科(中文轉繁體) · CC BY-SA 4.0 (derived zh-Hant)
ATC level L3 · Search this class · Consumer categories
Child classes
L01DAactinomycin Actinomicina 放线菌素 放線菌素L01DBAnthracyclines and related substances Anthracyclines and related substances 蒽环类药物 蒽環類藥物L01DCOther cytotoxic antibiotics Other cytotoxic antibiotics 其它细胞毒抗生素 其它細胞毒抗生素
Active ingredients in this class
23 active ingredients 23 principios activos 23 个活性成分 23 個有效成分
Each market now shows one aggregated status: a market counts as on sale if it has any active record; individual record statuses are shown in the details. The same market can also have several registration records with different statuses, so each market appears only once here; that is a record fact, not a safety judgement.
A missing name is marked in its row only when it is the exception; when most names lack it, the list stays unmarked.
- Doxorubicin
L01DB01Salt form: Doxorubicin Hydrochloride
Doxorubicin Hydrochlorideactive US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG CN ES MX TW EU · unknown HK - Daunorubicin
L01DB02Salt form: Daunorubicin Hydrochloride
Daunorubicin Hydrochlorideactive US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG CN ES MX TW EU · unknown HK - Bleomycin
L01DC01Salt form: Bleomycin Sulfate
Bleomycin Sulfateactive US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG CN ES MX TW · unknown HK - Epirubicin
L01DB03Salt form: Epirubicin Hydrochloride
Epirubicin Hydrochlorideactive US GB CA AU CN · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA AU CN ES MX TW · unknown HK - Mitomycin
L01DC03active US GB CA SG CN · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA SG CN ES TW · unknown AU HK - Idarubicin
L01DB06Salt form: Idarubicin Hydrochloride
Idarubicin Hydrochlorideactive US GB CA AU ES · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA AU ES TW · discontinued MX · unknown HK - Mitoxantrone
L01DBactive US GB CA SG CN · and 4 more y 4 más 另有 4 个 另有 4 個
active US GB CA SG CN TW · unknown AU HK - Dactinomycin
L01DA01active US GB CA SG CN · and 2 more y 2 más 另有 2 个 另有 2 個
active US GB CA SG CN · unknown AU - Mitoxantrona
L01DB07discontinued ES MX
discontinued ES MX - Daunorubicin (Liposomal)
L01DB02active GB · and 2 more y 2 más 另有 2 个 另有 2 個
active GB · unknown AU - Valrubicin
L01DB09active US · and 2 more y 2 más 另有 2 个 另有 2 個
active US · discontinued CA - Pixantrone
L01DB11active GB · and 2 more y 2 más 另有 2 个 另有 2 個
active GB · unknown EU - 盐酸伊达比星
L01DBactive CN
active CN - 盐酸平阳霉素
L01DCactive CN
active CN - 示踪用盐酸米托蒽醌
L01DBactive CN
active CN - 新福菌素
L01DAactive CN
active CN - Pirarubicin
L01DBactive CN
active CN - Mitomicina
L01DC03discontinued MX
discontinued MX - 盐酸阿柔比星
L01DBactive CN
active CN - 优替德隆
L01DCactive CN
active CN - Doxorubicin (Liposomal)
L01DB01active GB
active GB - Ixabepilona
L01DC04unknown MX
unknown MX - Pixantrona
L01DB11withdrawn ES
withdrawn ES
Class names are editorial translations or come from Wikipedia (CC BY-SA 4.0) / Wikidata (CC0); each ATC page lists the exact source, licence and link for every language. Only the ATC code and the WHO hierarchy are authoritative.
Notes & licences
Status badges summarise the product records held for each ingredient (active / discontinued / withdrawn / unknown), and the market codes after each badge show where that status is recorded. Only some registers publish a status column: CA, ES and MX do; AU and HK have no status column and are recorded as unknown; CN, US, GB, TW and SG records are on the register and marked active.
Class and category names are editorial or AI-assisted translations; only the ATC code and the WHO hierarchy are authoritative.
ATC codes and hierarchy reference the WHO Collaborating Centre for Drug Statistics Methodology ATC/DDD Index (copyright WHOCC; the index itself is not reproduced). Ingredient/strength facts come from the regulator records listed on About.